Who to call at Johnson & Johnson, and when
Fundz watches for the moments Johnson & Johnson starts buying, and tells you who to reach.
- An alert the day Johnson & Johnson raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Johnson & Johnson, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Johnson & Johnson. With Fundz connected, it knows.
Johnson & Johnson in discussions to acquire Ollin Biosciences for up to $3.4B to enhance its retinal disease treatment portfolio.
Contract Type
agreement
Description
Johnson & Johnson is currently negotiating to acquire Ollin Biosciences, a privately held biotech firm, for a potential total of $3.4 billion. This deal aims to bolster J&J's focus on treatments for retinal diseases, particularly through Ollin's lead drug candidate, OLN324, which targets critical conditions like wet AMD and DME.
Quick answer
Johnson & Johnson in discussions to acquire Ollin Biosciences for up to $3.4B to enhance its retinal disease treatment portfolio. (November 16, 2026). Johnson & Johnson is based in New Brunswick, New Jersey, United States.
- What agreement did Johnson & Johnson announce on November 16, 2026?
- Johnson & Johnson is currently negotiating to acquire Ollin Biosciences, a privately held biotech firm, for a potential total of $3.4 billion. This deal aims to bolster J&J's focus on treatments for retinal diseases, particularly through Ollin's lead drug candidate, OLN324, which targets critical conditions like wet AMD and DME.
- What does Johnson & Johnson do?
- For over 130 years, Johnson & Johnson has maintained a tradition of quality and innovation.
- Where is Johnson & Johnson based?
- Johnson & Johnson is based in New Brunswick, New Jersey, United States.
Source: Fundz verified event record.
Related People
Johnson & Johnson signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.